-
Diphtheria
-
Pertussis
-
Tetanus
Archived
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
MMWR, June 29, 2012; 61(25):468-70
Archived
Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, December 23, 2011; 60(50):1709-11
-
HPV (Human Papillomavirus)
Archived
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
MMWR, December 23, 2011; 60(50):1705-8
-
Diphtheria
-
Pertussis
-
Tetanus
Archived
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
MMWR, October 21, 2011; 60(41):1424-1426
Archived
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
MMWR, October 14, 2011; 60(40):1391-2
Archived
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011
MMWR, August 5, 2011; 60(30):1018-1019
-
Japanese Encephalitis (JE)
Archived
Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine -- Advisory Committee on Immunization Practices, 2011
MMWR, May 27, 2011; 60(20):661-3
-
Japanese Encephalitis (JE)
Archived
Update on Japanese Encephalitis Vaccine for Children
MMWR, May 27, 2011; 60(20):664-5
Archived
Updated Recommendations for Use of Meningococcal Conjugate Vaccines--Advisory Committee on Immunization Practices (ACIP), 2010
MMWR, January 28, 2011; 60(03):72-76
Archived
Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza
MMWR, January 21, 2011; 60(RR01):1-24
-
Diphtheria
-
Pertussis
-
Tetanus
Archived
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
MMWR, January 14, 2011; 60(01):13-15
-
Hepatitis A
-
Hepatitis B
-
HPV (Human Papillomavirus)
Archived
Sexually Transmitted Diseases Treatment Guidelines, 2010
MMWR, December 17, 2010; 59(RR12):1-110
Archived
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
MMWR, July 23, 2010; 59(rr06):1-36
-
HPV (Human Papillomavirus)
Archived
FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP)
MMWR, May 28, 2010; 59(20):626-629
-
HPV (Human Papillomavirus)
Archived
FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP) Weekly
MMWR, May 28, 2010; 59(20):630-632
Archived
Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged >=65 Years (Fluzone High-Dose) and Guidance for Use--United States, 2010
MMWR, April 30, 2010; 59(16):485-486
Archived
Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use--Advisory Committee on Immunization Practices (ACIP), 2010
MMWR, March 12, 2010; 59(09):273
Archived
Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children --- Advisory Committee on Immunization Practices (ACIP), 2010
MMWR, March 12, 2010; 59(09):258-261
-
Japanese Encephalitis (JE)
Archived
Japanese Encephalitis Vaccines
MMWR, March 12, 2010; 59(01):1-27
Archived
Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease
MMWR, September 25, 2009; 58(37):1042-1043
-
Hib (Haemophilus Influenzae Type B)
Archived
Licensure of a Haemophilus influenzae Type b (Hib) Vaccine (Hiberix) and Updated Recommendations for Use of Hib Vaccine
MMWR September 18, 2009; 58(36):1008-1009
Archived
Updated Recommendations from the Advisory Committee on Immunization Practices (ACIP) for Use of Hepatitis A Vaccine in Close Contacts of Newly Arriving International Adoptees
MMWR, September 18, 2009; 58(36):1006-1007
-
Hib (Haemophilus Influenzae Type B)
Archived
Updated Recommendations for Use of Haemophilus influenzae Type b (Hib) Vaccine: Reinstatement of the Booster Dose at Ages 12 -15 Months
MMWR, June 26, 2009; 58(24):673-4
Archived
Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection
MMWR, September 19, 2008; 57(RR--8):1-20
-
Diphtheria
-
Pertussis
-
Tetanus
Archived
Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, May 30, 2008; 57 (04):1-47,51
Archived
Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who Are Not Completely Vaccinated
MMWR, April 4, 2008; 57(13):343-344
Archived
Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2--10 Years at Increased Risk for Invasive Meningococcal Disease
MMWR, December 7, 2007; 56(48):1265-1266
Archived
Expansion of Use of Live Attenuated Influenza Vaccine (FluMist) to Children Aged 2-4 Years and Other FluMist Changes for the 2007--08 Influenza Season
MMWR, November 23, 2007; 56(46):1217-1219
Archived
Update: Prevention of Hepatitis A after Exposure to Hepatitis A Virus and in
MMWR, October 19, 2007; 56(41):1080-1084
Archived
Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine
MMWR, August 10, 2007; 56(31):794-795
-
HPV (Human Papillomavirus)
Archived
Quadrivalent Human Papillomavirus Vaccine
MMWR, March 23, 2007; 56(RR02):1-24
-
Diphtheria
-
Pertussis
-
Tetanus
Archived
Preventing Tetanus, Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
MMWR, December 15, 2006;55(RR-17):1-33
Archived
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part II: Immunization of Adults
If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
MMWR, December 8, 2006;55(RR-16):1-25R
Archived
Control and Elimination of Mumps
MMWR, June 9, 2006, Vol. 55(22):629-630
Archived
Prevention of Hepatitis A Through Active or Passive Immunization
MMWR, May 19, 2006, Vol. 55(RR07):1-23
-
Diphtheria
-
Pertussis
-
Tetanus
Archived
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among Adolescents
If you are using the HTML version of this document, be sure to access all the HTML links to get the complete content of the document, which includes important appendices.
MMWR, March 24, 2006, Vol. 55(RR03):1-49
Archived
Investigational Product (VariZIG™) for Postexposure Prophylaxis of Varicella
MMWR, February 24, 2006, Vol. 55:1-2
Archived
Influenza Vaccination of Health-Care Personnel
MMWR, February 24, 2006, Vol. 55(RR02):1-16
Archived
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part 1: Immunization of Infants, Children and Adolescents.
If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices
MMWR, December 23, 2005, Vol. 54(RR-16):1-39
Archived
CDC Treatment Guidelines: Recommended Antimicrobial Agents for the Treatment and Postexposure Prophylaxis of Pertussis
MMWR, December 9, 2005, Vol. 54(RR14):1-16
Archived
Prevention and Control of Meningococcal Disease
MMWR, May 27, 2005, Vol. 54(RR07):1-21
Archived
Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza
MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB)
Archived
Pneumococcal Vaccination for Cochlear Implant Candidates and Recipients
MMWR, Early Release, July 31, 2003, Vol. 52;1-2
Archived
Correctional Settings: Prevention and Control of Infections with Hepatitis Viruses in Correctional Settings
MMWR, January 24, 2003, Vol. 52(RR-1):1-44
Archived
Use of Anthrax Vaccine in Response to Terrorism
MMWR, November 15, 2002, Vol. 51(45):1024-1026
Archived
Yellow Fever Vaccine
MMWR, November 8, 2002, Vol. 51/RR17
Archived
CDC Guidelines: Evaluation and Management of Suspected Outbreaks, Rubella in Pregnant Women, and Surveillance for Congenital Rubella Syndrome
MMWR July 13, 2001 / Vol. 50 / No. RR-12
Archived
Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis
MMWR June 29, 2001 / Vol. 50 / No. RR-11
Archived
Use of Anthrax Vaccine in the United States
MMWR December 15, 2000 / Vol. 49 / No. RR-15
-
Diphtheria
-
Pertussis
-
Tetanus
Archived
Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series
MMWR November 17, 2000 / Vol. 49 / No. RR-13
Archived
Preventing Pneumococcal Disease Among Infants and Young Children
MMWR October 6, 2000 / Vol. 49 / No. RR-09
Archived
Prevention and Control of Meningococcal Disease
MMWR June 30, 2000 / Vol. 49 / No. RR-07
Archived
Meningococcal Disease and College Students
MMWR June 30, 2000 / Vol. 49 / No. RR-07
Archived
Measles, Mumps, and Rubella--Vaccine Use and Strategies
MMWR May 22, 1998 / Vol. 47 / No. RR-8
Archived
Prevention of Pneumococcal Disease
MMWR April 04, 1997 / Vol. 46 / No. RR-08
Archived
Use of Acellular Pertussis Vaccines
MMWR March 28, 1997 / Vol. 46 / No. RR-7
Archived
Typhoid Immunization
MMWR, December 9, 1994/ Vol. 43/ No. RR-14,
-
Hib (Haemophilus Influenzae Type B)
Archived
Use of Haemophilus b Conjugate Vaccines and a Combined DTP and Hib Vaccine
MMWR September 17, 1993 / Vol. 42 / No. RR-13
-
Japanese Encephalitis (JE)
Archived
Inactivated Japanese Encephalitis Virus Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR January 8, 1993;42(RR 01):1-15
Archived
Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States Through Universal Childhood Vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP)
MMWR November 22, 1991 / Vol 40/No. RR-13
Archived
Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States Through Universal Childhood Vaccination: Recommendations of the ACIP APPENDIX A: Postexposure Prophylaxis for Hepatitis B
MMWR November 22, 1991 / Vol 40/No. RR-13
Archived
Recommendations for Preventing Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Patients During Exposure-Prone Invasive Procedures
MMWR, July 12, 1991 / Vol. 40 / No. RR08
-
Hib (Haemophilus Influenzae Type B)
Archived
Haemophilus b Conjugate Vaccines for Prevention of Hib Disease
MMWR January 11, 1991 / Vol. 40 / No. RR-01
Archived
Protection Against Viral Hepatitis Recommendations of the Immunization Practices Advisory Committee (ACIP)
MMWR February 9, 1990 / Vol 39 / No. RR-2
